CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G' To Go Ex-Dividend On June 10th, 2024 With 0.81 USD Dividend Per Share

March 28th - $CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G'(CNLPL.US)$ is trading ex-dividend on June 10th, 2024. Shareholders of record on June 10th, 2024 will receive 0.81 USD dividend per

Futu NewsMar 28 09:40

CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G' To Go Ex-Dividend On March 7th, 2024 With 0.81 USD Dividend Per Share

January 10th - $CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G'(CNLPL.US)$ is trading ex-dividend on March 7th, 2024. Shareholders of record on March 8th, 2024 will receive 0.81 USD dividend p

Futu NewsJan 10 08:45

CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G' To Go Ex-Dividend On December 7th, 2023 With 0.81 USD Dividend Per Share

September 28th - $CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G'(CNLPL.US)$ is trading ex-dividend on December 7th, 2023. Shareholders of record on December 8th, 2023 will receive 0.81 USD di

Futu NewsSep 28, 2023 07:40

CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G' To Go Ex-Dividend On September 7th, 2023 With 0.81 USD Dividend Per Share

July 1st - $CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G'(CNLPL.US)$ is trading ex-dividend on September 7th, 2023. Shareholders of record on September 8th, 2023 will receive 0.81 USD divide

Futu NewsJul 1, 2023 07:45

CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G' To Go Ex-Dividend On June 8th, 2023 With 0.81 USD Dividend Per Share

June 7th - $CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G'(CNLPL.US)$ is trading ex-dividend on June 8th, 2023. Shareholders of record on June 9th, 2023 will receive 0.81 USD dividend per sha

Futu NewsJun 7, 2023 09:01

CDC expert group supports injection of Pfizer Inc for the elderly and high-risk groups

An advisory panel of experts from the US Centers for Disease Control and Prevention (CDC) voted on Thursday to recommend that the Pfizer Inc / BioNTech COVID-19 epidemic enhancement needle be provided to the elderly in the United States, nursing home residents and other vulnerable groups, clearing the way for the agency to make final approval at night at the earliest. The agency's Advisory Committee on Immunization practice unanimously agreed to provide a third dose of Pfizer Inc COVID-19 vaccine to people aged 65 and above and residents of sanatoriums. The group also recommended intensive injections for adults between the ages of 18 and 64 with underlying diseases and rejected plans to provide a wide range of enhanced needles to the American public. United States Food and Drug Administration (

新浪美股Sep 24, 2021 05:48